Atrial Fibrillation General Registry (AFGenLT)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02518984|
Recruitment Status : Completed
First Posted : August 10, 2015
Last Update Posted : May 15, 2020
|Condition or disease|
Given the advances in Atrial Fibrillation (AF) management and the availability of new European Society of Cardiology (ESC) guidelines, there is a need for the systematic collection of contemporary data regarding the management and treatment of AF in the member ESC countries. It is now nearly 10 years since the last European registry of AF management was undertaken (as part of the ESC Euro Heart Survey programme), and a new registry was needed.
New guidelines on the management of AF have recently been published by the ESC, but it remains unclear how often clinicians adhere to them. Since the last Euro Heart survey, a change in management strategy has necessitated an update on prevalent management practices in AF. This is influenced by clinical availability of catheter ablation as a routine procedure and new antiarrhythmic drugs, and also by developments in stroke thromboprophylaxis and medical therapy options. Under the EURObservational Research Programme (EORP), an AF ablation sentinel pilot registry was launched in 2010.
A survey of AF management under the EORP programme will enable a timely assessment of the uptake of the new ESC guidelines, allow monitoring of implementation and uptake of catheter ablation, new antithrombotic drugs and new antiarrhythmic agents, and will inform about outcomes related to guideline-adherent management of AF.
|Study Type :||Observational [Patient Registry]|
|Actual Enrollment :||19754 participants|
|Target Follow-Up Duration:||3 Years|
|Official Title:||Atrial Fibrillation General Long Term Registry|
|Actual Study Start Date :||October 2013|
|Actual Primary Completion Date :||August 2019|
|Actual Study Completion Date :||December 2019|
- vital status [ Time Frame: Baseline ]
- vital status [ Time Frame: one year follow-up ]
- vital status [ Time Frame: two year follow-up ]
- vital status [ Time Frame: three year follow-up ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02518984
|European Society of Cardiology|
|Biot, France, 06903|
|Study Chair:||Gregory Lip, MD||European Society of Cardiology|